You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Invert sugar - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for invert sugar and what is the scope of freedom to operate?

Invert sugar is the generic ingredient in one branded drug marketed by Baxter Hlthcare and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for invert sugar
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 42
Clinical Trials: 2
Patent Applications: 5,211
DailyMed Link:invert sugar at DailyMed
Recent Clinical Trials for invert sugar

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Federal University of São PauloPhase 3
University of CalgaryN/A

See all invert sugar clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for invert sugar

US Patents and Regulatory Information for invert sugar

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare TRAVERT 10% IN PLASTIC CONTAINER invert sugar INJECTABLE;INJECTION 016717-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Invert sugar Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory of Invert Sugar

Introduction to Invert Sugar

Invert sugar, a liquid sweetener produced from a combination of granulated sugar and water, has been gaining significant traction in the global market. This sweetener is renowned for its enhanced sweetness, improved texture, and various applications across multiple industries.

Market Size and Growth Projections

The global invert sugar market has demonstrated robust growth in recent years. As of 2023, the market size was valued at USD 2,315.81 million and is projected to grow to USD 3,459.63 million by 2032, exhibiting a compound annual growth rate (CAGR) of 4.62% during the forecast period[1][4].

Regional Market Analysis

Asia Pacific Dominance

The Asia Pacific region dominates the invert sugar market, accounting for a market share of 42.16% in 2023. Countries such as China, Indonesia, and India are key contributors to this dominance due to the high availability of raw materials and the rapidly growing food processing industry in these regions[1].

U.S. Market Growth

The U.S. market is also expected to grow significantly, with the invert sugar market size projected to reach an estimated value of USD 392.45 million by 2032. This growth is driven by the increasing use of inverted sugar in various applications, including food & beverage and pharmaceuticals[1].

Key Drivers of Market Growth

Increasing Demand for Confectioneries

The growing demand for confectioneries, particularly in countries like China, Japan, and Singapore, is a major driver of market growth. Premium confections are increasingly popular as high-quality gifts, leading manufacturers to focus on creating innovative candies and chocolate bars to appeal to a broader consumer base[1].

Expanding Food and Beverage Industry

The food and beverage industry's expansion, driven by convenience, changing lifestyles, and cost affordability, is propelling the demand for processed foods and beverages. Invert sugar, used to improve flavor, texture, and shelf life, is a key component in these products[4].

Pharmaceutical Applications

Invert sugar is increasingly used in pharmaceutical formulations as a sweetening agent, stabilizer, and carbohydrate source in parenteral nutrition solutions. The growth in pharmaceutical production, particularly in Europe, is driving this segment of the market[4].

Technological Advancements

Companies in the invert sugar market are investing heavily in research and development to enhance production capabilities and deliver sustainable products. For instance, Invert Sugar India Ltd. uses Combined Cycle Technology (CCT) that employs enzymes for the production of inverted sugar syrup, resulting in superior quality products compared to traditional methods[1].

Market Segmentation

By Type

The fully inverted sugar segment is expected to be the leading segment in the global market, driven by its widespread use in various applications[1].

By Nature

The market is segmented into organic and conventional invert sugar, with a growing trend towards organic and sustainably sourced ingredients due to consumer demand for healthier options[4].

By Application

Invert sugar is used as a sweetener, texturizing agent, and preservative across different industries. Its unique attributes make it a preferred choice in products like pastry fillings and ganache[2][4].

Challenges and Hindrances

Adverse Health Effects of High Sugar Consumption

Despite the growth prospects, the invert sugar market faces challenges due to the adverse health effects associated with high sugar consumption. This has led to increased consumer awareness and a shift towards healthier alternatives, which could impede market growth[1].

Key Players and Market Competition

The global invert sugar market is competitive, with prominent players such as Nordzucker AG, Archer Daniels Midland Company, and Cargill Incorporated. These companies are focusing on innovative technologies and sustainable practices to maintain their market position[1].

Financial Trajectory

The financial trajectory of the invert sugar market is promising, with steady growth projected over the next few years. Here are some key financial milestones:

  • 2023: The global market size was valued at USD 2,315.81 million[1].
  • 2024: The market is expected to grow to USD 2,410.93 million[1].
  • 2032: Projected to reach USD 3,459.63 million, with a CAGR of 4.62% during the forecast period[1].
  • 2028: Another projection indicates the market will grow to USD 2.84 billion at a CAGR of 5.0%[4].

Conclusion

The invert sugar market is poised for significant growth driven by increasing demand from the food and beverage industry, pharmaceutical applications, and technological advancements. Despite challenges related to health consciousness, the market's financial trajectory indicates a robust and steady expansion in the coming years.

Key Takeaways

  • The global invert sugar market is valued at USD 2,315.81 million in 2023 and is projected to grow to USD 3,459.63 million by 2032.
  • Asia Pacific dominates the market, with a significant contribution from China, Indonesia, and India.
  • The U.S. market is expected to grow substantially, driven by increasing use in food & beverage and pharmaceuticals.
  • Technological advancements and sustainable practices are key drivers of market growth.
  • Adverse health effects of high sugar consumption pose a challenge to market expansion.

FAQs

Q: What is the current market size of the global invert sugar market? A: The global invert sugar market size was valued at USD 2,315.81 million in 2023[1].

Q: What is the projected CAGR of the invert sugar market from 2024 to 2032? A: The market is projected to exhibit a CAGR of 4.62% during the forecast period from 2024 to 2032[1].

Q: Which region dominates the invert sugar market? A: The Asia Pacific region dominates the invert sugar market, accounting for a market share of 42.16% in 2023[1].

Q: What are the primary applications of invert sugar? A: Invert sugar is used as a sweetener, texturizing agent, and preservative in various industries, including food, beverages, and pharmaceuticals[2][4].

Q: How does technological advancement impact the invert sugar market? A: Technological advancements, such as Combined Cycle Technology (CCT), enhance production capabilities and deliver sustainable products, driving market growth[1].

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.